These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 12491487)
1. Breast cancer genetics in African Americans. Olopade OI; Fackenthal JD; Dunston G; Tainsky MA; Collins F; Whitfield-Broome C Cancer; 2003 Jan; 97(1 Suppl):236-45. PubMed ID: 12491487 [TBL] [Abstract][Full Text] [Related]
2. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. Nanda R; Schumm LP; Cummings S; Fackenthal JD; Sveen L; Ademuyiwa F; Cobleigh M; Esserman L; Lindor NM; Neuhausen SL; Olopade OI JAMA; 2005 Oct; 294(15):1925-33. PubMed ID: 16234499 [TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Pal T; Permuth-Wey J; Holtje T; Sutphen R Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1794-9. PubMed ID: 15533909 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Gao Q; Tomlinson G; Das S; Cummings S; Sveen L; Fackenthal J; Schumm P; Olopade OI Hum Genet; 2000 Aug; 107(2):186-91. PubMed ID: 11030417 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Meindl A; Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209 [TBL] [Abstract][Full Text] [Related]
6. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Armstrong K; Micco E; Carney A; Stopfer J; Putt M JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311 [TBL] [Abstract][Full Text] [Related]
7. Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases. Kanaan Y; Kpenu E; Utley K; Adams-Campbell L; Dunston GM; Brody LC; Broome C Hum Genet; 2003 Oct; 113(5):452-60. PubMed ID: 12942367 [TBL] [Abstract][Full Text] [Related]
8. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada]. Tonin PN Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226 [TBL] [Abstract][Full Text] [Related]
9. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry. Zhang J; Fackenthal JD; Zheng Y; Huo D; Hou N; Niu Q; Zvosec C; Ogundiran TO; Hennis AJ; Leske MC; Nemesure B; Wu SY; Olopade OI Breast Cancer Res Treat; 2012 Jul; 134(2):889-94. PubMed ID: 22739995 [TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Hall MJ; Reid JE; Burbidge LA; Pruss D; Deffenbaugh AM; Frye C; Wenstrup RJ; Ward BE; Scholl TA; Noll WW Cancer; 2009 May; 115(10):2222-33. PubMed ID: 19241424 [TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Capalbo C; Ricevuto E; Vestri A; Ristori E; Sidoni T; Buffone O; Adamo B; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G Ann Oncol; 2006 Jun; 17 Suppl 7():vii34-40. PubMed ID: 16760289 [TBL] [Abstract][Full Text] [Related]
12. BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies. Pal T; Vadaparampil S; Betts J; Miree C; Li S; Narod SA Genet Test; 2008 Sep; 12(3):401-7. PubMed ID: 18752448 [TBL] [Abstract][Full Text] [Related]
13. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160 [TBL] [Abstract][Full Text] [Related]
14. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067 [TBL] [Abstract][Full Text] [Related]
15. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. Haffty BG; Silber A; Matloff E; Chung J; Lannin D J Med Genet; 2006 Feb; 43(2):133-7. PubMed ID: 15983021 [TBL] [Abstract][Full Text] [Related]
16. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer. Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591 [TBL] [Abstract][Full Text] [Related]
17. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. Newman B; Mu H; Butler LM; Millikan RC; Moorman PG; King MC JAMA; 1998 Mar; 279(12):915-21. PubMed ID: 9544765 [TBL] [Abstract][Full Text] [Related]
18. Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families. Verhoog LC; van den Ouweland AM; Berns E; van Veghel-Plandsoen MM; van Staveren IL; Wagner A; Bartels CC; Tilanus-Linthorst MM; Devilee P; Seynaeve C; Halley DJ; Niermeijer MF; Klijn JG; Meijers-Heijboer H Eur J Cancer; 2001 Nov; 37(16):2082-90. PubMed ID: 11597388 [TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management. Marchina E; Fontana MG; Speziani M; Salvi A; Ricca G; Di Lorenzo D; Gervasi M; Caimi L; Barlati S Oncol Rep; 2010 Dec; 24(6):1661-7. PubMed ID: 21042765 [TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]